Breaking boundaries
With technology evolving at breakneck speed, it’s fair to say that the sky is the limit when it comes to the use of virtual therapeutics
Read More
Search Results for: Paula Bellostas Muguerza and Afonso de Brito Canelas
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
